Home › Calculator › CLGN Dividend Calculator 2026
CLGN Dividend DRIP Calculator 2026
547.95% YieldHealthcareCollPlant Biotechnologies Ltd. · NASDAQ
Price: $0.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CLGN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CLGN snowball 📈
$10,000 in CLGN → $10247310080986417152.00M in 10 years · $853,790,341,966,242,200,000,000.00/month
About CollPlant Biotechnologies Ltd. (CLGN) — Dividend Analysis 2026
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen. Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores. The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.
Compare CLGN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CLGN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CLGN position with:
🌍 CLGN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CLGN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 547.95% | 545.15% | $54,795 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 465.76% | 462.96% | $46,576 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 438.36% | 435.56% | $43,836 / yr |
| 🇬🇧 UK ISA | 0% | 547.95% | 545.15% | $54,795 / yr |
| 🇬🇧 UK Taxable | 8.75% | 500.00% | 497.20% | $50,000 / yr |
| 🇨🇦 TFSA | 0% | 547.95% | 545.15% | $54,795 / yr |
| 🇨🇦 CA Taxable | 25% | 410.96% | 408.16% | $41,096 / yr |
| 🇦🇺 Super (pension) | 15% | 465.76% | 462.96% | $46,576 / yr |
| 🇦🇺 AU Taxable | 30% | 383.56% | 380.76% | $38,357 / yr |
| 🇩🇪 DE Taxable | 26.375% | 403.43% | 400.63% | $40,343 / yr |
| 🇫🇷 FR Taxable | 30% | 383.56% | 380.76% | $38,357 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CLGN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CLGN Dividend Payment Schedule
CLGN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CLGN vs Healthcare Benchmarks
How CLGN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CLGN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CLGN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2023-05-02 | 24,000 | $6.39 | $153.4K | ||
| Other | 2023-05-02 | 100,000 | $6.39 | $639.0K | ||
| Other | 2020-05-18 | 37,800 | $4.02 | $152.0K | ||
| Other | 2023-05-02 | 47,000 | $6.39 | $300.3K | ||
| Other | 2019-01-14 | 10,000 | $4.02 | $40.2K | ||
| Other | 2023-05-02 | 24,000 | $6.39 | $153.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where CLGN earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CLGN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CollPlant Biotechnologies Ltd. (CLGN) is currently trading at $0.37, 98% below its 52-week high. The current dividend yield is 547.95% based on an annual payout of $2.00 per share.
CLGN (CollPlant Biotechnologies Ltd.) — 547.95% Dividend Yield Analysis
CollPlant Biotechnologies Ltd. (CLGN) is a healthcare stock currently trading at $0.36 with a dividend yield of 547.95%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (547.95%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.